We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Book and Media Reviews |

Diagnostic Pediatric Hematopathology

Paulette Mehta, MD, MPH
JAMA. 2012;307(17):1867-1868. doi:10.1001/jama.307.17.1867.
Text Size: A A A
Published online


Hematopathology is the backbone of diagnosis of all hematologic and bone marrow diseases and as such is crucial for categorizing disease, designing treatment, following results, and comparing regimens. Precise hematopathology diagnosis is central to understanding the underlying molecular pathophysiology of disease and thereby in revealing potential new targets for experimental therapy. The issues in hematopathologic diagnosis are much more intricate in children compared with adults because pathology changes with physiology—thus, as the child develops, the types of hematopoietic disease vary not just by age and developmental stage of the child but also by age and stage of the affected organ. Additionally, some congenital syndromes diagnosed in childhood are associated with hematopoietic conditions that may appear malignant to the untrained observer but actually may be benign and even transient, as occurs in patients with Down syndrome. Also, a number of “small round blue cell tumors,” eg, neuroblastoma, Ewing sarcoma, or rhabdomyosarcoma, may masquerade as leukemia and require expert analysis for correct identification. These and other quandaries are unique to pediatrics and pivotal to proper diagnosis and treatment.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.